An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder

被引:15
|
作者
Ellis, Laura Peyton [1 ]
Parlier-Ahmad, Anna Beth [2 ]
Scheikl, Marjorie [3 ,4 ]
Martin, Caitlin E. [3 ,4 ,5 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[2] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA USA
[3] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA
[4] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA
[5] 1101 East Marshall St,11th Floor,Room 11-027,Box 9, Richmond, VA 23298 USA
关键词
addiction; integrated care; opioid use disorder; postpartum; pregnancy; ASSISTED TREATMENT; WOMEN; DEPENDENCE; RETENTION; OUTCOMES;
D O I
10.1097/ADM.0000000000001052
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
ObjectivesPerinatal opioid use disorder is increasing. Integrated obstetric/addiction care models likely optimize parent-infant dyad outcomes, but the ideal combination of services is unknown. This study (1) describes pregnancy-to-postpartum service utilization by people receiving buprenorphine at an integrated Obstetric/Addiction Clinic and (2) explores the association between service utilization and postpartum buprenorphine continuation.MethodsThis retrospective medical record review study uses research registry data from an outpatient Obstetric/Addiction Clinic. All patients are invited to participate in the research registry. For patients who consent, monthly medical record abstractions are conducted beginning with their first clinic visit to collect demographic, obstetric, and substance use disorder treatment variables. Present analyses included patients who delivered an infant between June 2019 and June 2021, started buprenorphine during pregnancy, and were receiving buprenorphine at delivery. Overall service utilization was the number of services (range 0-12) used between 28-weeks gestation and 12-weeks postpartum. Bivariate analyses and multivariable logistic regression assessed associations between service utilization and buprenorphine continuation.ResultsParticipants (n = 42) were primarily non-Latinx White (67%) with comorbid psychiatric diagnoses (95%). On average, participants used 6 services; prenatal care, mental health care, and postpartum contraception were most utilized. Overall, 69% of participants continued buprenorphine at 6 months postpartum. This did not differ by level of service utilization (bivariate [P = 0.07], multivariable [P = 0.16]).ConclusionIntegrated care with a harm reduction focus supports pregnancy-to-postpartum service utilization and buprenorphine continuation in a patient sample at high risk for medication for opioid use disorder discontinuation. Further work is needed to identify evidence-based methods to individualize integrated obstetric/addiction care.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [41] Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder
    Parlier-Ahmad, Anna Beth
    Pugh, Mickeal, Jr.
    Martin, Caitlin E.
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2022, 9 (04) : 1557 - 1567
  • [42] Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder
    Anna Beth Parlier-Ahmad
    Mickeal Pugh
    Caitlin E. Martin
    Journal of Racial and Ethnic Health Disparities, 2022, 9 : 1557 - 1567
  • [43] State Policy Variation in Implementation of Federal Drug and Child Abuse Laws and Stigmatization of Pregnant and Postpartum Individuals with Opioid Use Disorder
    Peltier, MacKenzie R.
    Pegram, Destiny D.
    Chander, Geetanjali
    Weisner, Constance M.
    Mckee, Sherry A.
    Jones, Hendree E.
    Chang, Grace
    JOURNAL OF WOMENS HEALTH, 2025,
  • [44] The Pharmacist-Integrated Medication Treatment for Opioid Use Disorder (PrIMO) Model: Operationalizing an Effective Clinical Care Model to Assess Feasibility in Diverse Care Settings
    Homsted, Felicity
    Gardner, Trip
    Nesin, Noah
    McGrady, Frank R.
    Fiellin, David
    Joudrey, Paul
    McLeman, Bethany
    Gauthier, Phoebe
    Moore, Sarah K.
    Marsch, Lisa
    Ghitza, Udi
    Rao, Deepika
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [45] Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention
    Ray-Griffith, Shona
    Tharp, Emily
    Coker, Jessica L.
    Catlin, David
    Knight, Bettina
    Stowe, Zachary N.
    AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (01): : 43 - 48
  • [46] Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
    Katherine M. Rich
    Joshua Bia
    Frederick L. Altice
    Judith Feinberg
    Current HIV/AIDS Reports, 2018, 15 : 266 - 275
  • [47] Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
    Rich, Katherine M.
    Bia, Joshua
    Altice, Frederick L.
    Feinberg, Judith
    CURRENT HIV/AIDS REPORTS, 2018, 15 (03) : 266 - 275
  • [48] Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol
    Bryan, M. Aryana
    Smid, Marcela C.
    Cheng, Melissa
    Fortenberry, Katherine T.
    Kenney, Amy
    Muniyappa, Bhanu
    Pendergrass, Danielle
    Gordon, Adam J.
    Cochran, Gerald
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2020, 15 (01)
  • [49] Experiences of Discrimination and Treatment Outcomes Among Pregnant and Postpartum People With Opioid Use Disorder
    Xu, Joyce
    DeFranco, Emily
    Murnan, Aaron
    Nidey, Nichole
    Terplan, Mishka
    Wilder, Christine
    OBSTETRICS AND GYNECOLOGY, 2023, 141 : 37S - 37S
  • [50] Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol
    M. Aryana Bryan
    Marcela C. Smid
    Melissa Cheng
    Katherine T. Fortenberry
    Amy Kenney
    Bhanu Muniyappa
    Danielle Pendergrass
    Adam J. Gordon
    Gerald Cochran
    Addiction Science & Clinical Practice, 15